NCT02843607已完成1 期
Combination of Cryosurgery and NK Immunotherapy for Advanced Kidney Cancer
Fuda Cancer Hospital, Guangzhou1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2016年7月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Relief degree
研究概览
简要总结
The aim of this study is the safety and efficacy of cryosurgery plus NK immunotherapy to advanced kidney cancer.
详细描述
By enrolling patients with kidney cancer adapted to enrolled criteria, this study will document for the first time the safety and the short and long term efficacy of the combined therapy using cryosurgery and nature killer (NK) cells for advanced kidney cancer.
The safety will be evaluated by statistics of adverse reactions. The efficacy will be evaluated according to local relief degree, progress free survival (PFS) and overall survival (OS).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 30 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All standard therapies have failed according to NCCN guidelines or the patient refuses standard therapies after cancer recurrence
- •Body tumor 1-6, the maximum tumor length < 5 cm
- •KPS ≥ 70, lifespan > 6 months
- •Platelet count ≥ 80×109/L，white blood cell count ≥ 3×109/L, neutrophil count ≥ 2×109/L, hemoglobin ≥ 80 g/L
排除标准
- •Patients with cardiac pacemaker
- •Patients with brain metastasis
- •Patients with grade 3 hypertension or diabetic complication, severe cardiac and pulmonary dysfunction
结局指标
主要结局
Relief degree
时间窗: 3 months
It will be evaluated by the Response Evaluation Criteria in Solid Tumors（RECIST）
次要结局
- Progress free survival（PFS）(1 year)
- Overall survival（OS）(3 years)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Combination of Cryosurgery and NK Immunotherapy for Advanced Esophageal CancerMetastatic Esophageal CancerNCT02843581Fuda Cancer Hospital, Guangzhou60
已完成
1 期
Combination of Cryosurgery and NK Immunotherapy for Advanced Liver CancerSecondary Malignant Neoplasm of LiverNCT02843802Fuda Cancer Hospital, Guangzhou30
已完成
1 期
Combination of Cryosurgery and NK Immunotherapy for Advanced Breast CancerBreast Cancer RecurrentNCT02844335Fuda Cancer Hospital, Guangzhou60
已完成
1 期
Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung CancerNon-small Cell Lung Cancer MetastaticNCT02843815Fuda Cancer Hospital, Guangzhou30
已完成
1 期
Combination of Cryosurgery and NK Immunotherapy for Recurrent SarcomaRecurrent Adult Soft Tissue SarcomaNCT02849366Fuda Cancer Hospital, Guangzhou30